Thayer Martin Medium Base: Composition
Thayer Martin Medium Base: Composition
Thayer Martin Medium Base used for selective isolation of Gonococci from pathological specimens.
Composition**
Ingredients Gms / Litre
Peptone, special 23.000
Starch 1.000
Sodium chloride 5.000
Agar 13.000
Final pH ( at 25°C) 7.0±0.2
**Formula adjusted, standardized to suit performance parameters
Directions
Suspend 21.0 grams in 450 ml distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15
lbs pressure (121°C) for 15 minutes. Cool to 45°C. Aseptically add 50 ml of sterile lysed blood and rehydrated contents of one
vial of Vitamino Growth Supplement (FD025) and V.C.N Supplement (FD023) or V.C.N.T Supplement (FD024). If desired
GC Supplement with Antibiotics (FD021) can be used as a single supplement. Mix well before pouring into sterile Petri plates.
If Hemoglobin (FD022) is used suspend 21.0 grams of Thayer Martin Medium Base in 250 ml distilled water.Heat to boiling
to dissolve the medium completely. Prepare 250 ml of 2% hemoglobin solution. Sterilize separately by autoclaving at 15 lbs
pressure (121°C) for 15 minutes. Cool to 45°C. Mix both and add the supplements as above.
Quality Control
Appearance
Cream to yellow homogeneous free flowing powder
Gelling
Firm, comparable with 1.3% Agar gel.
Colour and Clarity of prepared medium
Basal Medium : Yellow coloured clear to slightly opalescent gel. After addition of haemoglobin or sterile lysed blood and
supplements: chocolate coloured opaque gel forms in Petri plates.
Reaction
Reaction of 4.2% w/v aqueous solution at 25°C. pH : 7.0±0.2
pH
6.80-7.20
Cultural Response
M413: Cultural characteristics observed with added sterile lysed blood/Haemoglobin solution (FD022), Vitamino Growth
Supplement (FD025) and V.C.N. Supplement (FD023)/V.C.N.T. Supplement (FD024) after an incubation at 35-37°C for
18-48 hours.
Organism Inoculum Growth Recovery Colour of
(CFU) colony
Reference
1. Carpenter and Morton, 1947, Proc. N.Y. State Assoc. Public Hlth. Labs., 27:58.
2. Carpenter et al, 1949, Am. J. Syphil. Gonorrh. Vener. Dis., 33:164.
3. Martin, Billings, Hackney and Thayer, 1967, Public Hlth. Rep., 82:361.
4. Thayer J. and Martin J.E. Jr., 1966, Public Health Rep., 81:559.
5. Martin J.E. Jr. and Lester A., 1971, HSMHA Hlth. Service Rep., 86(1):30.
6. MacFaddin J., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. I, Williams and
Wilkins, Baltimore.
Revision : 1 / 2011
Disclaimer :
User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained in
this and other related HiMedia™ publications. The information contained in this publication is based on our research and development
work and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes to
specifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use but
for laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not
be considered as a warranty of any kind, expressed or implied, and no liability is accepted for infringement of any patents.
HiMedia Laboratories Pvt. Ltd. A-516,Swastik Disha Business Park,Via Vadhani Ind. Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6147
1919 Email: [email protected]